return to news
  1. Apollo Hospitals Q1 results: Net profit rises 42% to ₹433 crore, EBITDA jumps 26%; margin expands by 130 bps

Market News

Apollo Hospitals Q1 results: Net profit rises 42% to ₹433 crore, EBITDA jumps 26%; margin expands by 130 bps

Upstox

2 min read | Updated on August 12, 2025, 19:41 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

The Hyderabad-based company's revenue from operations in April-June period rose 15% annually to ₹5,842 crore from ₹5,086 crore in the year-ago period.

Stock list

Apollo Hospitals.webp

Apollo Hospitals shares ended 0.24% higher at ₹7,236.60 ahead of its earnings announcement.

Apollo Hospitals, the country's largest private hospital chain operator, on Tuesday, August 12, reported net profit of ₹433 crore in the first quarter of the current financial year (Q1FY26), marking an upside of 42% from ₹305 crore in the same period last year.

Open FREE Demat Account within minutes!
Join now

The Hyderabad-based company's revenue from operations in the April-June period rose 15% annually to ₹5,842 crore from ₹5,086 crore in the year-ago period.

Apollo Hospitals posted stable operational performance as its operating profit, also known as EBITDA (earnings before interest, taxes, depreciation and amortisation), rose 26% to ₹852 crore from ₹675 crore in the corresponding period last year. The company's EBITDA margin expanded by 130 basis points to 14.58% from 13.27%.

The company earned ₹2,974 crore in revenue from healthcare services, ₹435 crore from retail health and diagnostics business, and revenue from digital health and pharmacy distribution came in at ₹2,472 crore.

Profit from healthcare services came in at ₹562 crore, and profit from the digital health and pharmacy distribution business came in at ₹69 crore.

The company announced that it has acquired a 50% stake in Apollo Gleneagles PET-CT Private Limited (AGPCL) from Parkway Healthcare (Mauritius) PTE Limited for ₹8.5 crore.

The objective of the acquisition is to consolidate ownership and have full control over AGPCL's operations, enabling better integration with the Company's diagnostic services and improving operational efficiencies, Apollo Hospitals said in a regulatory filing.

During the quarter, Apollo Hospitals acquired 450,000 equity shares of ₹2/- each of Apollo HealthTech Limited from the existing shareholders at par value, for a total consideration of ₹9,00,000/-, and consequent to the said acquisition, Apollo HealthTech Limited became a wholly owned subsidiary of the company, Apollo Hospitals added.

Apollo Hospitals shares ended 0.24% higher at ₹7,236.60 ahead of its earnings announcement.

SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story